Cells Speak.
We Listen.

At Soley Therapeutics, we leverage the human cell as the most powerful sensor and capture its response to stress and drug exposure with proprietary imaging, AI, and automation that allow us to translate whole cell information into first-in-class medicines with speed and scale.

The Drug Discovery Challenge

Medicines to Match Disease Complexity

One target was once the limit.

Complex diseases involve stressed cells responding through many different signaling networks, surviving when they should die, as in cancer, or failing when they should recover, as in neurodegeneration and many other chronic diseases. Capturing the complexity of disease requires going beyond a single target and instead viewing whole cell behavior.

Today, we can use the whole cell.

Soley maps the information about drugs that living cells sense and consequently respond to by uncovering how each cell decides to adapt, recover, or die. Our biology-first approach uncovers medicines and mechanisms other methods miss and provides insight into selectivity, safety, and patient fit for translation into the clinic.

Biology at Scale

Built for Clinical Impact

Soley Therapeutics is discovering novel medicines and therapeutic mechanisms uncovered with an unprecedented understanding of the information sensed by cells and consequently whole cell behavior under stress conditions.

Biology Leads

Platform informed by Nobel-inspired discoveries and decades of research on how cells sense and respond to stress.

Cells Guide the Way

Real-time mapping of whole-cell sensing uncovers novel biology and guides more precise drug discovery.

First-in-Class Medicines

Advancing a pipeline of innovative medicines with new mechanisms across oncology and non-oncology complex diseases.

Cells Speak. We Listen.